Incidence of Transfusion-Related Adverse Reactions per Patient Reflects the Potential Risk of Transfusion Therapy in Japan-Reference-Cited by-同舟云学术

Incidence of Transfusion-Related Adverse Reactions per Patient Reflects the Potential Risk of Transfusion Therapy in Japan

Published:2013-08-01 Issue:2 Volume:140 Page:219-224
ISSN:1943-7722
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Kato Hidefumi¹,Uruma Motoaki¹,Okuyama Yoshiki²,Fujita Hiroshi³,Handa Makoto⁴,Tomiyama Yoshiaki⁵,Shimodaira Shigetaka⁶,Kurata Yoshiyuki⁷,Takamoto Shigeru¹⁸

Affiliation:

1. Department of Transfusion Medicine, Aichi Medical University, Nagakute, Aichi, Japan

2. Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan

3. Department of Transfusion Medicine, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan

4. Department of Transfusion Medicine & Cell Therapy, Keio University, Tokyo, Japan

5. Department of Blood Transfusion, Osaka University Hospital, Osaka, Japan

6. Division of Transfusion Medicine, Shinshu University Hospital, Matsumoto-shi, Nagano-ken, Japan

7. Department of Human Welfare, Shitennoji University, Habikino, Japan

8. Japanese Red Cross Hokkaido Block Blood Center, Sapporo, Japan

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/140/2/219/24994900/ajcpath140-0219.pdf

Reference18 articles.

1. Current risk for transfusion transmitted infections;Dodd;Curr Opin Hematol,2007

2. Klein HG Lipton KS . Noninfectious serious hazards of transfusion. AABB Association Bulletin 01–4. 2001. http://www.aabb.org/resources/publications/bullentins/Pages/ab01-4.aspx.

3. US Food and Drug Administration . Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2010. Rockville, MD: US Food and Drug Administration, Center for Biologics Evaluation & Research. 2011. http://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReporaProblem/TransfusionDonationFatalities/UCM254860.pdf.

4. Haemovigilance: an effective tool for improving transfusion practice;de Vries;Vox Sang,2011

5. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998;Andreu;Transfusion,2002

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of acute transfusion reactions and associated factors among adult blood-transfused patients at Jimma University Medical Center, southwest Ethiopia: A cross-sectional study;Medicine;2024-08-09

2. Review of haemovigilance at the Rabat Regional Blood Transfusion Centre in Morocco (2017-2021);The Pan African Medical Journal;2024

3. Non-infectious Causes of Blood Transfusion Reactions: A Tertiary Hospital Review;Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy;2023-12-28

4. Donor pregnancies and transfusion recipient mortality: A role for red blood cell storage?;Vox Sanguinis;2023-11-03

5. Transfusion reactions associated with COVID‐19 convalescent plasma in outpatient clinical trials;Transfusion;2023-08-03